Contact Us News & Media Font Size Home About Us Products Research Responsibility Investor Relations News & Media Careers COLEMAN LANNUM Core Strengths Executive Team Executive Committee Mark Trudeau Mark Casey Meredith Fischer Matthew Harbaugh Ron Lloyd Hugh O'Neill Gary Phillips, M.D. Steven Romano, M.D. Dr. Frank Scholz Karen Sheehy Ian Watkins Select Senior Leaders Coleman Lannum Tunde Otulana, M.D. Dagmar Rosa-Björkeson Kathleen Schaefer Board of Directors 150th Anniversary Our Story Inclusion and Diversity Partnering News & Media Blog Patient Stories Careers at Mallinckrodt Community Outreach Investor Relations Coleman Lannum Senior Vice President of Investor Strategy and Investor Relations Officer Coleman (Cole) Lannum is the senior vice president of investor strategy and investor relations officer at Mallinckrodt Pharmaceuticals. He has responsibility for integrating investor relations with all corporate strategic functions and strengthening investor relations communications both internally and throughout the broader investment community. Mr. Lannum is a member of Mallinckrodt’s finance leadership team. Prior to joining Mallinckrodt in 2015, Mr. Lannum led investor relations at Covidien and Tyco, where he served as Vice President and Investor Relations Officer. During his nine years at Covidien, Mr. Lannum’s leadership was recognized with an unprecedented number of investor relations best-in-class awards from 2008-2015, including best investment community meetings, best earnings calls, and best financial reporting. Previously, Mr. Lannum held investment leadership roles at Putnam Investments, as well as Boatmen’s Trust and American Express Asset Management (both now part of Columbia Asset Management). Mr. Lannum holds a bachelor’s degree in business administration from Washington University, and an MBA from Texas A&M University. He has been a Chartered Financial Analyst since 1991. Back Building On Our Heritage Nearly 150 years of quality, integrity and service. Learn More Our Culture From philanthropic efforts to advocacy initiatives, we are living our hallmarks throughout our communities. Learn How Resources for: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Blog LinkedIn + Cookies Policy Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies setting, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies. I Agree ›